Depression News and Research

Latest Depression News and Research

Depression and distress among medical students

Medical students with moderate to severe depression more frequently endorsed several depression stigma attitudes than nondepressed students and had a higher rate of suicidal thoughts, according to a study in the September 15 issue of JAMA, a theme issue on medical education.

15 Sep 2010

Study on spinal cord stem cells paves way for post stroke symptom treatment

Neuralstem, Inc. announced that its spinal cord stem cells survived in rat brains affected by stroke and differentiated predominantly into neurons. The transplanted animals showed significant improvement in some motor skill and strength measurements. The study entitled, "Intracerebral Implantation of Adherent Human Neural Stem Cells To Reverse Motor Deficits in Chronic Stroke Rats," was presented earlier today by senior study author, Dr. Shinn-Zong Lin, M.D., Ph.D., at the Stem Cells USA & Regenerative Medicine Conference

15 Sep 2010

Medical students experience high rate of depression than general population: Study

Medical students experience depression at a higher rate than the general population and attach high levels of stigma to the mental illness, according to U-M research to be published Sept. 15 in the Journal of the American Medical Association.

15 Sep 2010

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.

15 Sep 2010

Heart patients with Type D personality at higher risk of future cardiovascular problems

Heart patients with the "distressed" (Type D) personality profile may face a higher risk of future cardiovascular problems, according to a summary article published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

15 Sep 2010

Researchers identify risk gene for schizophrenia

An international team of researchers has identified a risk gene for schizophrenia, including a potentially causative mutation, using genome-wide association data-mining techniques and independent replications.

15 Sep 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.

14 Sep 2010

Mini-Psych School 2010 program to focus on mental health in children, youth

For the past five years, the Douglas Mental Health University Institute has been offering the Mini-Psych School, the only public education program of its kind in Quebec. This year, the program will be focussing on mental health in children and youth.

14 Sep 2010

Emergency physicians to present research studies at Research Forum 2010

The risks associated with boarding admitted patients in the emergency department – including patient mortality – as well as proposed solutions will be key themes of Scientific Assembly, the annual meeting of the American College of Emergency Physicians. In addition, emergency physicians will present more than 450 research studies during 2010 Research Forum, the premier, annual scientific research event focused on the latest advances in the practice of emergency medicine.

14 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

Metabolon receives patent for metabolic age analysis

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,781,160 entitled "Biomarkers Related to Metabolic Age and Methods Using the Same". The USPTO awarded the patent to Metabolon on August 24, 2010. This is the 12th patent issued to Metabolon.

14 Sep 2010

Depression in children and teens need to be treated early

Depression in children and teenagers can be very debilitating and can have a lifelong impact. Parents who suspect their child, even their youngster, might be depressed should seek help right away rather than simply hope their child will eventually "grow out of it."

14 Sep 2010

Laser acupuncture a plausible treatment for depression

Acupuncture produces significant changes in parts of the brain that regulate emotional states and is a biologically plausible treatment for depression and other neuropsychiatric disorders, Australian researchers have shown for the first time.

13 Sep 2010

DSP Clinical Research ranked #1674 on Inc. 5000 list

DSP Clinical Research achieved a ranking of No. 1674 on the prestigious Inc. 5000 list. DSP provides customized contract research services for small to mid-size pharmaceutical and biotechnology companies conducting Phase I to IV clinical studies.

13 Sep 2010

Heart Failure Society of America's 14th Annual Scientific Meeting convenes September 12, 2010

The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting -- a forum for heart failure specialists to present research findings and advances in treatment -- will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.

13 Sep 2010

Current economic crisis threatens to affect cancer incidence: Report

Although overall mortality from cancer is decreasing in the European Union, its incidence increased by almost 20%, from 2.1 million new cases in 2002 to 2.5 million in 2008, says a special issue of the European Journal of Cancer on cancer prevention, published today.

13 Sep 2010

Accord reached on draft declaration for MDG summit

World powers have reached an accord, after weeks of tough talks, on a document to be adopted at a Millennium Development summit this month for which [U.N.] Secretary General Ban Ki-moon is seeking billions of dollars of new funding,Agence France-Presse reports in an article that describes how representatives from donor and developing nations debated how best to pay for a kick start to the ambitious development goals first set at the Millennium summit in 2000.

13 Sep 2010

NAADAC and Hazelden partner to improve treatment for co-occurring disorders

NAADAC, the Association for Addiction Professionals, and Hazelden, the national nonprofit focused on addiction treatment, prevention and recovery announced today a new strategic partnership focused on improving the treatment of co-occurring disorders. The partnership announcement was made by NAADAC Executive Director Cynthia Moreno Tuohy during the National Conference on Addiction Disorders in Washington, D.C.

10 Sep 2010

Researchers present study results of psychosocial trauma experienced at 2006 Dawson College shooting

A research team from the McGill University Health Centre (MUHC) and Fernand-Seguin Research Centre of Louis-H. Lafontaine Hospital presented today the results of its three-year study, a world first, into the 2006 Dawson College shooting to the Government of Quebec's Ministry of Public Security.

10 Sep 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.

10 Sep 2010

Depression News and Research

Latest Depression News and Research

Depression and distress among medical students

Study on spinal cord stem cells paves way for post stroke symptom treatment

Medical students experience high rate of depression than general population: Study

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Heart patients with Type D personality at higher risk of future cardiovascular problems

Researchers identify risk gene for schizophrenia

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

Mini-Psych School 2010 program to focus on mental health in children, youth

Emergency physicians to present research studies at Research Forum 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Metabolon receives patent for metabolic age analysis

Depression in children and teens need to be treated early

Laser acupuncture a plausible treatment for depression

DSP Clinical Research ranked #1674 on Inc. 5000 list

Heart Failure Society of America's 14th Annual Scientific Meeting convenes September 12, 2010

Current economic crisis threatens to affect cancer incidence: Report

Accord reached on draft declaration for MDG summit

NAADAC and Hazelden partner to improve treatment for co-occurring disorders

Researchers present study results of psychosocial trauma experienced at 2006 Dawson College shooting

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in